Changing Treatment Landscape in the Initial Management of Metastatic Castrate-Resistant Prostate Cancer (mCRPC): An Australian Multi-Centre Retrospective Study

被引：0
|
作者：
Kwan, E. [1 ,2 ]
Semira, C. [3 ,4 ]
Muttiah, C. [5 ]
Beck, S. [3 ,4 ]
Anton, A. [4 ]
Tran, B. [3 ,4 ]
机构：
[1] Monash Hlth, Dept Med Oncol, Melbourne, Vic, Australia
[2] Monash Univ, Sch Clin Sci, Dept Med, Melbourne, Vic, Australia
[3] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic, Australia
[4] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalised Med, Melbourne, Vic, Australia
[5] Western Hlth, Dept Med Oncol, Melbourne, Vic, Australia
来源：
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：48 / 49
页数：2
相关论文
共 50 条
  • [31] Therapy With Metronomic Cyclophosphamide (mCyc) for Previously-Treated Metastatic Castrate-Resistant Prostate Cancer (mCRPC)
    Mar, Nataliya
    Dwabe, Sami
    Baranda, Marlon N.
    Zarrabi, Kevin K.
    Eturi, Aditya
    Gulati, Shuchi
    Parikh, Mamta
    Seyedin, Steven N.
    Kalebasty, Arash Rezazadeh
    CLINICAL GENITOURINARY CANCER, 2024, 22 (02) : 217 - 223
  • [32] Use of low-dose, weekly carboplatin in men with metastatic castrate-resistant prostate cancer (mCRPC).
    O'Leary-Kelly, Meghan
    Gao, Dexiang
    Weisdack, Sarah
    Lam, Elaine Tat
    Bernard, Brandon David
    Flaig, Thomas W.
    Kessler, Elizabeth Riley
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [33] Genomic landscape of MSH6-mutated clinically advanced castrate-resistant prostate cancer (mCRPC).
    Bratslavsky, Gennady
    Decker, Brennan
    Jacob, Joseph M.
    Necchi, Andrea
    Spiess, Philippe E.
    Grivas, Petros
    Lin, Douglas I.
    Ramkissoon, Shakti H.
    Severson, Eric Allan
    Huang, Richard S. P.
    Mata, Douglas A.
    Madison, Russell
    Montesion, Meagan
    Gjoerup, Ole
    Sokol, Ethan
    Pavlick, Dean C.
    Danziger, Natalie
    Ross, Jeffrey S.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [34] Management of non-metastatic castrate-resistant prostate cancer: A systematic review
    Loriot, Yohann
    Supiot, Stephane
    Beauval, Jean-Baptiste
    Schlurmann, Friederike
    Pasticier, Gilles
    Sargos, Paul
    Barthelemy, Philippe
    Pignot, Geraldine
    Maillet, Denis
    Vincendeau, Sebastien
    Gross, Emmanuel
    Ploussard, Guillaume
    Timsit, Marc-Olivier
    Borchiellini, Delphine
    CANCER TREATMENT REVIEWS, 2018, 70 : 223 - 231
  • [35] Management and challenges of corticosteroid therapy in men with metastatic castrate-resistant prostate cancer
    Dorff, T. B.
    Crawford, E. D.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 31 - 38
  • [36] Racial disparities in efficacy of first-line abiraterone in metastatic castrate-resistant prostate cancer (mCRPC).
    Marar, Mallika
    Long Qi
    Mamtani, Ronac
    Narayan, Vivek
    Vapiwala, Neha
    Parikh, Ravi Bharat
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [37] Economic burden of the management of metastatic castrate-resistant prostate cancer in Italy: a cost of illness study
    Restelli, Umberto
    Ceresoli, Giovanni Luca
    Croce, Davide
    Evangelista, Laura
    Maffioli, Lorenzo Stefano
    Gianoncelli, Letizia
    Bombardieri, Emilio
    CANCER MANAGEMENT AND RESEARCH, 2017, 9 : 789 - 800
  • [38] A safety study of cabozantinib (C) plus docetaxel (D) and prednisone (P) in metastatic castrate-resistant prostate cancer (mCRPC).
    Karzal, Fatima
    Shah, Avani Atul
    Ojemuyiwa, Michelle A.
    Madan, Ravi Amrit
    Apolo, Andrea Borghese
    Dawson, Nancy Ann
    Arlen, Phillp M.
    Theoret, Marc Robert
    Wright, John Joseph
    Chen, Clara
    Trepel, Jane B.
    Couvillon, Anna
    Chun, Guinevere
    Harold, Nancy
    Steinberg, Seth M.
    Price, Douglas K.
    Gulley, James L.
    Figg, William Douglas
    Dahut, William L.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [39] The use of intermittent enzalutamide dosing in the treatment of metastatic castrate-resistant prostate cancer
    Rowe, Michael
    Hidayat, Ayesha
    Walter, Stuart
    Pollard, Adam
    Norris, Timothy
    Victor, Deborah
    McGrane, John
    Thomson, Alastair
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [40] Medication Payments by Insurers and Patients for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Kaye, Deborah R.
    Lee, Hui-Jie
    Gordee, Alexander
    George, Daniel J.
    Ubel, Peter A.
    Scales, Charles D.
    Bundorf, M. Kate
    JCO ONCOLOGY PRACTICE, 2023, 19 (04) : 214 - +
12345